Metabolism of extracellular pyrophosphate

Current Opinion in Rheumatology

Volumn 15, Issue 3, 2003, Pages 311-314

  Ryan, Lawrence M ^a   Rosenthal, Ann K ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYTOKINE; GROWTH FACTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C; PYROPHOSPHATE;

CARTILAGE CELL; CARTILAGE MATRIX; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; JOINT; METABOLISM; MINERAL BALANCE; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCINOSIS; CALCIUM PYROPHOSPHATE; CARTILAGE, ARTICULAR; CHONDROCALCINOSIS; CHONDROCYTES; EXTRACELLULAR SPACE; FEMALE; HOMEOSTASIS; HUMANS; MALE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0038746715     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200305000-00020     Document Type: Review

References (32)

1. Ho AM, Johnson MD, Kingsley DM: Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000, 289:265-270. This article provides the definitive identification of the genetic abnormality underlying progressive murine ankylosis.
2. Okawa A, Nakamura I, Goto S, et al.: Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 1998, 19:271-273.
3. Hessle L, Johnson KA, Anderson CA, et al.: Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Nat Acad Sci U S A 2002, 99:9445-9449.
4. Nurnberg P, Thiele H, Chandler D, et al.: Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet 2001, 28:37-41.
5. Reichenberger E, Tiziani V, Watanabe S, et al.: Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet 2001, 68:1321-1326.
6. Rutsch F, Schaurte P, Kalhoff H, et al.: Low levels of urinary inorganic pyrophosphate indicating systemic pyrophosphate deficiency in a boy with idiopathic infantile arterial calcification. Acta Paediatr 2000, 89:1265-1269.
7. Rutsch F, Vaingankar S, Johnson K, et al.: PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001, 158:543-554. This is an outstanding dissection of the abnormal pyrophosphate metabolism in this rare disease associated with arterial and periarticular calcification.
8. Pendleton A, Johnson M, Hughes A, et al.: Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 2002, 71:933-940.
9. Williams C, Zhang Y, Timms A, et al.: Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH. Am J Hum Genet 2002, 71:985-991.
10. Fedde KN, Blair L, Silverstein J, et al.: Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999, in press.
11. Johnson K, Hessle L, Vaingankar S, et al.: Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol 2000, 279:P1365-P1377.
12. Ryan LM: The ank gene story. Arthritis Res 2001, 3:77-79.
13. Hirose J, Ryan L, Masuda I: Up-regulated expression of cartilage intermediate-layer protein and ANK in articular cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 2002, in press.
14. Masuda I, Hamada J, Haas AL, et al.: A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. J Clin Invest 1995, 95:699-704.
15. Braunstein G, Roman R, Clancy J, et al.: Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem 2001, 276:6621-6630.
16. Graft RD, Lazarowski ER, Banes AJ, et al.: ATP release by mechanically loaded porcine chondrins in pellet culture. Arthritis Rheum 2000, 43:1571-1579. This is the first report of ATP release by chondrocytes.
17. Rosenthal AK, Ryan LM: Ageing increases growth factor-induced inorganic pyrophosphate elaboration by articular cartilage. Mech Ageing Dev 1994, 75:35-44.
18. Rosen F, McCabe G, Quach J, et al.: Differential effects of aging on human chondrocyte responses to transforming growth factor β: increased pyrophosphate production and decreased cell proliferation. Arthritis Rheum 1997, 40:1275-1281.
19. Rosenthal AK, Derfus BA, Henry LA: Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum 1997, 40:966-970.
20. Rosenthal AK, Gohr CM, Henry LA, et al.: Participation of transglutaminase in the activation of latent transforming growth factor beta 1 in aging articular cartilage. Arthritis Rheum 2000, 43:1729-1733.
21. Rosenthal AK, Masuda I, Gohr CM, et al.: The transglutaminase, factor XIIIA, is present in articular chondrocytes. Osteoarthritis Cartilage 2001, 9:578-581. This study identifies factor XIIIA as a transglutaminase in articular chondrocytes.
22. Johnson K, Hashimoto S, Lotz M, et al.: Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 2001, 159:149-163.
23. Rosenthal AK, Cheung HS, Ryan LM: Transforming growth factor B1 stimulates inorganic pyrophosphate elaboration by porcine cartilage. Arthritis Rheum 1991, 34:904-911.
24. Hirose J, Masuda I, Ryan LM: Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. Arthritis Rheum 2000, 43:2703-2711.
25. Sohn P, Crowley E, Slattery E, et al.: Developmental and TGF-B-mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthritis Cartilage 2002, 10:482-490.
26. Rosenthal AK, Henry LA: Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes. Calcif Tissue Int 1996, 59:128-133.
27. Rosenthal AK, Henry LA: Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes. J Rheumatol 1999, 26:395-401.
28. Ryan LM, Kurup I, Cheung HS: Stimulation of cartilage inorganic pyrophosphate elaboration by ascorbate. Matrix 1991, 11:276-281.
29. Terkeltaub RA: Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol 2001, 281:01-011. This is an excellent review of PPi metabolism.
30. Olmez U, Ryan LM, Kurup IV, et al.: Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage. Osteoarthritis Cartilage 1004, 2:149-154.
31. Ryan LM, Kurup IV, Cheung HS: Transduction mechanisms of porcine chondrocyte inorganic pyrophosphate elaboration. Arthritis Rheum 1999, 42:555-560.
32. Masuda I, Barbieri J, Hewlett E, et al.: Inhibition of chondrocyte pyrophsophate elaboration by bacterial toxin (abst). Arthritis Rheum 2002, 46:S81.